Mots-C
Mitochondrial open reading frame of the 12S rRNA-c, MT-RNR1, Mitochondrial-derived peptide MOTS-c
The mitochondrial-derived peptide MOTS-c promotes homeostasis in aged human placenta-derived mesenchymal stem cells in vitro.
Yu. Won Dong WD; Kim. Yu Jin YJ; Cho. Min Jeong MJ; Seok. Jin J; Kim. Gi Jin GJ; Lee. Chang-Han CH; Ko. Jung Jae JJ; Kim. You Shin YS; Lee. Jae Ho JH
Key Findings
- MOTS‑c improved the shape and appearance of aged stem cells.
- It strongly activated AMPK and suppressed mTORC1, pathways linked to metabolism and aging.
- Mitochondrial function became more youthful: lower oxygen consumption, less ROS, and reduced lipid synthesis.
Practical Outcomes
- The results suggest MOTS‑c could support cellular health and metabolic balance, which is attractive for anti‑aging strategies. However, the work was done only in cell cultures, so there’s no human dosage or safety data yet. Biohackers should treat this as early‑stage evidence and wait for clinical trials before using MOTS‑c as a supplement.
Summary
A lab study found that adding the tiny protein MOTS‑c to old human placenta stem cells made the cells look healthier, turned on a key energy‑sensing pathway (AMPK), turned down a growth pathway (mTORC1), lowered their oxygen use and harmful reactive oxygen species, and reduced fat‑making activity. The treated cells behaved more like young cells.
Abstract
Mesenchymal stem cells (MSCs) are multipotent cells with critical roles in homeostasis and regeneration. MSCs undergo aging in response to various stresses, and this causes many diseases including degenerative disorders. Thus, regulation of aging factors is crucial for healthy aging. Mitochondrial open reading frame of the 12S rRNA-c (MOTS-c) was recently reported to regulate metabolic homeostasis. Here, we investigated the restorative effects of MOTS-c on aged human placenta-derived MSCs (hPD-MSCs). MOTS-c promoted the morphology of old hPD-MSCs. MOTS-c significantly activated AMP-activated protein kinase, which is the main target pathway of MOTS-c, and inhibited its antagonistic effector mTORC1. MOTS-c considerably enhanced mitochondrial homeostasis by decreasing oxygen consumption and reactive oxygen species production. The mitochondrial state of MOTS-c-treated old hPD-MSCs was more similar to that of young hPD-MSCs than the mitochondrial state of non-treated old hPD-MSCs. MOTS-c also decreased lipid synthesis. In conclusion, we demonstrated that MOTS-c promotes homeostasis in aged hPD-MSCs.
Study Information
pubmed
2021
2021-02-24T00:00:00.000Z
10.1016/j.mito.2021.02.010
15
27